| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.24e-04 | 231 | 67 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | POU domain binding | 2.30e-04 | 7 | 67 | 2 | GO:0070974 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 2.86e-04 | 507 | 67 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 2.86e-04 | 507 | 67 | 8 | GO:0030695 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor binding | 3.51e-04 | 41 | 67 | 3 | GO:0005154 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 6.70e-04 | 51 | 67 | 3 | GO:0001784 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 7.16e-04 | 12 | 67 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 8.45e-04 | 13 | 67 | 2 | GO:0001162 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 8.45e-04 | 13 | 67 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 8.45e-04 | 13 | 67 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 9.83e-04 | 14 | 67 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | caspase binding | 1.29e-03 | 16 | 67 | 2 | GO:0089720 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 1.46e-03 | 17 | 67 | 2 | GO:0001161 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 1.61e-03 | 69 | 67 | 3 | GO:0045309 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 2.03e-03 | 20 | 67 | 2 | GO:0050664 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 2.68e-03 | 23 | 67 | 2 | GO:0071837 | |
| GeneOntologyBiologicalProcess | Fc-epsilon receptor signaling pathway | 1.08e-06 | 25 | 65 | 4 | GO:0038095 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 9.19e-06 | 42 | 65 | 4 | GO:0099560 | |
| GeneOntologyBiologicalProcess | trophectodermal cell fate commitment | 2.93e-05 | 3 | 65 | 2 | GO:0001830 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 3.84e-05 | 60 | 65 | 4 | GO:0099054 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 4.37e-05 | 62 | 65 | 4 | GO:0038093 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 6.54e-05 | 25 | 65 | 3 | GO:0002433 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 6.54e-05 | 25 | 65 | 3 | GO:0038096 | |
| GeneOntologyBiologicalProcess | presynapse organization | 8.30e-05 | 73 | 65 | 4 | GO:0099172 | |
| GeneOntologyBiologicalProcess | ectodermal cell fate commitment | 9.72e-05 | 5 | 65 | 2 | GO:0001712 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.67e-04 | 34 | 65 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 1.82e-04 | 35 | 65 | 3 | GO:0002431 | |
| GeneOntologyBiologicalProcess | ectoderm formation | 2.03e-04 | 7 | 65 | 2 | GO:0001705 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 2.52e-04 | 39 | 65 | 3 | GO:0038094 | |
| GeneOntologyBiologicalProcess | regulation of pro-B cell differentiation | 2.70e-04 | 8 | 65 | 2 | GO:2000973 | |
| GeneOntologyBiologicalProcess | regulation of presynapse assembly | 3.14e-04 | 42 | 65 | 3 | GO:1905606 | |
| GeneOntologyBiologicalProcess | ectodermal cell differentiation | 3.47e-04 | 9 | 65 | 2 | GO:0010668 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 3.61e-04 | 44 | 65 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | regulation of presynapse organization | 4.12e-04 | 46 | 65 | 3 | GO:0099174 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 4.12e-04 | 46 | 65 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | germ-line stem cell population maintenance | 4.33e-04 | 10 | 65 | 2 | GO:0030718 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 5.28e-04 | 11 | 65 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion-dependent exocytosis | 5.28e-04 | 11 | 65 | 2 | GO:0045955 | |
| GeneOntologyBiologicalProcess | regulation of lymphoid progenitor cell differentiation | 6.32e-04 | 12 | 65 | 2 | GO:1905456 | |
| GeneOntologyBiologicalProcess | pro-B cell differentiation | 7.46e-04 | 13 | 65 | 2 | GO:0002328 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 7.46e-04 | 13 | 65 | 2 | GO:0038133 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 8.14e-04 | 58 | 65 | 3 | GO:0097106 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.60e-04 | 157 | 68 | 5 | GO:0098839 | |
| Domain | Vav | 4.41e-08 | 3 | 67 | 3 | IPR028530 | |
| Domain | GDS_CDC24_CS | 2.67e-07 | 39 | 67 | 5 | IPR001331 | |
| Domain | CAMSAP_CH | 1.53e-06 | 7 | 67 | 3 | PF11971 | |
| Domain | CAMSAP_CH | 1.53e-06 | 7 | 67 | 3 | IPR022613 | |
| Domain | DH_1 | 3.05e-06 | 63 | 67 | 5 | PS00741 | |
| Domain | RhoGEF | 4.47e-06 | 68 | 67 | 5 | SM00325 | |
| Domain | RhoGEF | 5.16e-06 | 70 | 67 | 5 | PF00621 | |
| Domain | DH_2 | 5.16e-06 | 70 | 67 | 5 | PS50010 | |
| Domain | DH-domain | 5.53e-06 | 71 | 67 | 5 | IPR000219 | |
| Domain | - | 5.53e-06 | 71 | 67 | 5 | 1.20.900.10 | |
| Domain | - | 1.89e-05 | 321 | 67 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 2.20e-05 | 328 | 67 | 8 | IPR032675 | |
| Domain | POU_dom_5 | 3.79e-05 | 3 | 67 | 2 | IPR015585 | |
| Domain | Cyt_b245_heavy_chain | 7.57e-05 | 4 | 67 | 2 | IPR000778 | |
| Domain | PH | 1.70e-04 | 229 | 67 | 6 | PF00169 | |
| Domain | NAD_binding_6 | 2.63e-04 | 7 | 67 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 2.63e-04 | 7 | 67 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 2.63e-04 | 7 | 67 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 2.63e-04 | 7 | 67 | 2 | IPR013121 | |
| Domain | LRR_8 | 3.70e-04 | 171 | 67 | 5 | PF13855 | |
| Domain | Leu-rich_rpt | 4.20e-04 | 271 | 67 | 6 | IPR001611 | |
| Domain | Leu-rich_rpt_typical-subtyp | 4.34e-04 | 177 | 67 | 5 | IPR003591 | |
| Domain | LRR_TYP | 4.34e-04 | 177 | 67 | 5 | SM00369 | |
| Domain | PH | 4.81e-04 | 278 | 67 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.90e-04 | 279 | 67 | 6 | PS50003 | |
| Domain | PH_domain | 4.99e-04 | 280 | 67 | 6 | IPR001849 | |
| Domain | ALDOKETO_REDUCTASE_1 | 5.60e-04 | 10 | 67 | 2 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 5.60e-04 | 10 | 67 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 5.60e-04 | 10 | 67 | 2 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 5.60e-04 | 10 | 67 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 5.60e-04 | 10 | 67 | 2 | PS00063 | |
| Domain | ENOYL_COA_HYDRATASE | 5.60e-04 | 10 | 67 | 2 | PS00166 | |
| Domain | SM22_calponin | 6.83e-04 | 11 | 67 | 2 | IPR003096 | |
| Domain | LRR | 7.72e-04 | 201 | 67 | 5 | PS51450 | |
| Domain | Ferric_reduct | 8.18e-04 | 12 | 67 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 8.18e-04 | 12 | 67 | 2 | IPR013130 | |
| Domain | Ras_G-nucl-exch_fac_CS | 1.12e-03 | 14 | 67 | 2 | IPR019804 | |
| Domain | C1_1 | 1.12e-03 | 57 | 67 | 3 | PF00130 | |
| Domain | LRR_1 | 1.13e-03 | 219 | 67 | 5 | PF00560 | |
| Domain | - | 1.32e-03 | 746 | 67 | 9 | 3.40.50.300 | |
| Domain | POU | 1.47e-03 | 16 | 67 | 2 | SM00352 | |
| Domain | POU_2 | 1.47e-03 | 16 | 67 | 2 | PS00465 | |
| Domain | POU_dom | 1.47e-03 | 16 | 67 | 2 | IPR000327 | |
| Domain | POU_3 | 1.47e-03 | 16 | 67 | 2 | PS51179 | |
| Domain | Pou | 1.47e-03 | 16 | 67 | 2 | PF00157 | |
| Domain | - | 1.47e-03 | 16 | 67 | 2 | 3.20.20.100 | |
| Domain | POU_1 | 1.47e-03 | 16 | 67 | 2 | PS00035 | |
| Domain | ZF_DAG_PE_1 | 1.57e-03 | 64 | 67 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.57e-03 | 64 | 67 | 3 | PS50081 | |
| Domain | C1 | 1.64e-03 | 65 | 67 | 3 | SM00109 | |
| Domain | CH | 1.64e-03 | 65 | 67 | 3 | SM00033 | |
| Domain | NADP_OxRdtase_dom | 1.67e-03 | 17 | 67 | 2 | IPR023210 | |
| Domain | Crotonase_core_superfam | 1.67e-03 | 17 | 67 | 2 | IPR001753 | |
| Domain | POU | 1.67e-03 | 17 | 67 | 2 | IPR013847 | |
| Domain | Aldo_ket_red | 1.67e-03 | 17 | 67 | 2 | PF00248 | |
| Domain | ECH_1 | 1.67e-03 | 17 | 67 | 2 | PF00378 | |
| Domain | Aldo/ket_red/Kv-b | 1.67e-03 | 17 | 67 | 2 | IPR001395 | |
| Domain | PE/DAG-bd | 1.72e-03 | 66 | 67 | 3 | IPR002219 | |
| Domain | CH | 2.03e-03 | 70 | 67 | 3 | PF00307 | |
| Domain | Fd_Rdtase_FAD-bd | 2.08e-03 | 19 | 67 | 2 | IPR017927 | |
| Domain | FAD_FR | 2.08e-03 | 19 | 67 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 2.08e-03 | 19 | 67 | 2 | IPR017938 | |
| Domain | - | 2.12e-03 | 71 | 67 | 3 | 1.10.418.10 | |
| Domain | CH | 2.29e-03 | 73 | 67 | 3 | PS50021 | |
| Domain | RasGEFN | 2.31e-03 | 20 | 67 | 2 | SM00229 | |
| Domain | CH-domain | 2.48e-03 | 75 | 67 | 3 | IPR001715 | |
| Domain | F-box_dom | 2.48e-03 | 75 | 67 | 3 | IPR001810 | |
| Domain | RasGEF_N | 2.55e-03 | 21 | 67 | 2 | PF00618 | |
| Domain | - | 2.55e-03 | 21 | 67 | 2 | 3.90.226.10 | |
| Domain | ClpP/crotonase-like_dom | 2.55e-03 | 21 | 67 | 2 | IPR029045 | |
| Domain | - | 2.76e-03 | 391 | 67 | 6 | 2.30.29.30 | |
| Domain | Ras-like_Gua-exchang_fac_N | 2.80e-03 | 22 | 67 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 2.80e-03 | 22 | 67 | 2 | PS50212 | |
| Domain | NACHT | 3.06e-03 | 23 | 67 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 3.06e-03 | 23 | 67 | 2 | IPR007111 | |
| Domain | P-loop_NTPase | 3.16e-03 | 848 | 67 | 9 | IPR027417 | |
| Domain | RASGEF | 3.90e-03 | 26 | 67 | 2 | PS00720 | |
| Pathway | SA_B_CELL_RECEPTOR_COMPLEXES | 2.74e-08 | 24 | 54 | 5 | M17200 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 3.07e-07 | 175 | 54 | 8 | MM15599 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 3.90e-07 | 75 | 54 | 6 | M5436 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 4.51e-07 | 184 | 54 | 8 | M41809 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY | 5.28e-07 | 5 | 54 | 3 | M48994 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 5.33e-07 | 79 | 54 | 6 | M11816 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 8.90e-07 | 20 | 54 | 4 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 8.90e-07 | 20 | 54 | 4 | MM14991 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.55e-06 | 52 | 54 | 5 | MM14743 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.80e-06 | 97 | 54 | 6 | M9400 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 2.92e-06 | 59 | 54 | 5 | M11215 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 3.18e-06 | 60 | 54 | 5 | MM14913 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 3.37e-06 | 108 | 54 | 6 | M9904 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 6.84e-06 | 70 | 54 | 5 | MM14824 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.03e-05 | 76 | 54 | 5 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.09e-05 | 77 | 54 | 5 | MM15044 | |
| Pathway | PID_RAC1_REG_PATHWAY | 1.29e-05 | 38 | 54 | 4 | M241 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.32e-05 | 80 | 54 | 5 | M800 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 1.33e-05 | 137 | 54 | 6 | M5669 | |
| Pathway | WP_PDGF_PATHWAY | 1.59e-05 | 40 | 54 | 4 | M39555 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 1.59e-05 | 40 | 54 | 4 | M39695 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 1.63e-05 | 142 | 54 | 6 | MM15431 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.77e-05 | 85 | 54 | 5 | MM14746 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.88e-05 | 14 | 54 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 1.88e-05 | 14 | 54 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.88e-05 | 14 | 54 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.88e-05 | 14 | 54 | 3 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.88e-05 | 14 | 54 | 3 | M47488 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.99e-05 | 87 | 54 | 5 | M27205 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M47531 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 2.58e-05 | 154 | 54 | 6 | M27697 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 2.75e-05 | 93 | 54 | 5 | MM15609 | |
| Pathway | PID_RHOA_REG_PATHWAY | 2.78e-05 | 46 | 54 | 4 | M68 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 2.78e-05 | 46 | 54 | 4 | MM15837 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 2.78e-05 | 46 | 54 | 4 | M8626 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CYBB ARAP3 EHHADH NOX3 SLITRK3 VAV3 MAPK3 VAV1 VAV2 SOS1 SOS2 | 2.84e-05 | 649 | 54 | 11 | MM15690 |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.87e-05 | 16 | 54 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.87e-05 | 16 | 54 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 2.87e-05 | 16 | 54 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 2.87e-05 | 16 | 54 | 3 | M47804 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 2.87e-05 | 16 | 54 | 3 | M39882 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 2.87e-05 | 16 | 54 | 3 | M47483 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 2.89e-05 | 94 | 54 | 5 | M41818 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 3.48e-05 | 17 | 54 | 3 | M47376 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 3.81e-05 | 165 | 54 | 6 | M39400 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 3.89e-05 | 439 | 54 | 9 | MM15595 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 4.44e-05 | 343 | 54 | 8 | MM15712 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 4.71e-05 | 450 | 54 | 9 | M27078 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 4.93e-05 | 19 | 54 | 3 | M47733 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 7.00e-05 | 184 | 54 | 6 | MM15943 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 7.00e-05 | 58 | 54 | 4 | MM14914 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | CYBB DCAF1 FBXW10B SEC24D FBXW10 EHHADH KEAP1 FBXO32 ANAPC5 VAV1 SOS1 | 7.21e-05 | 719 | 54 | 11 | MM14540 |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 7.88e-05 | 188 | 54 | 6 | MM15828 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 7.88e-05 | 188 | 54 | 6 | M4844 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 7.93e-05 | 116 | 54 | 5 | M2164 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 8.91e-05 | 23 | 54 | 3 | M45013 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.02e-04 | 24 | 54 | 3 | M27553 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.02e-04 | 24 | 54 | 3 | M11190 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.08e-04 | 199 | 54 | 6 | M7253 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.15e-04 | 25 | 54 | 3 | MM15269 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.23e-04 | 67 | 54 | 4 | MM15327 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.46e-04 | 27 | 54 | 3 | M27422 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 1.46e-04 | 27 | 54 | 3 | M1718 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 1.46e-04 | 27 | 54 | 3 | MM15693 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 1.56e-04 | 213 | 54 | 6 | M18306 | |
| Pathway | REACTOME_DAP12_SIGNALING | 1.81e-04 | 29 | 54 | 3 | M27171 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.00e-04 | 30 | 54 | 3 | MM15170 | |
| Pathway | WP_PROLACTIN_SIGNALING | 2.01e-04 | 76 | 54 | 4 | M39601 | |
| Pathway | REACTOME_DAP12_SIGNALING | 2.21e-04 | 31 | 54 | 3 | MM14886 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.44e-04 | 32 | 54 | 3 | MM1355 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 2.65e-04 | 150 | 54 | 5 | MM14889 | |
| Pathway | WP_MAPK_CASCADE | 2.67e-04 | 33 | 54 | 3 | M39594 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 2.67e-04 | 33 | 54 | 3 | M9494 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 3.19e-04 | 35 | 54 | 3 | M47379 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.19e-04 | 35 | 54 | 3 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.19e-04 | 35 | 54 | 3 | M773 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 3.24e-04 | 86 | 54 | 4 | M27206 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.38e-04 | 87 | 54 | 4 | M27617 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 3.38e-04 | 87 | 54 | 4 | MM15600 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 3.52e-04 | 720 | 54 | 10 | M41838 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 3.53e-04 | 88 | 54 | 4 | M41810 | |
| Pathway | WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE | 3.76e-04 | 37 | 54 | 3 | M45513 | |
| Pathway | WP_EGFEGFR_SIGNALING | 3.78e-04 | 162 | 54 | 5 | M39334 | |
| Pathway | WP_TCELL_RECEPTOR_SIGNALING | 3.85e-04 | 90 | 54 | 4 | M39725 | |
| Pathway | WP_MIRNAS_AND_TFS_IN_IPS_CELL_GENERATION | 3.97e-04 | 8 | 54 | 2 | MM15855 | |
| Pubmed | 1.93e-11 | 12 | 68 | 5 | 15728722 | ||
| Pubmed | 2.00e-10 | 6 | 68 | 4 | 17984307 | ||
| Pubmed | Vav family proteins are required for optimal regulation of PLCgamma2 by integrin alphaIIbbeta3. | 7.15e-09 | 3 | 68 | 3 | 17054426 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 26240279 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 23935450 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 32963234 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 14623913 | ||
| Pubmed | Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. | 7.15e-09 | 3 | 68 | 3 | 8990121 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 32528129 | ||
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 29136506 | ||
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 1.17e-08 | 38 | 68 | 5 | 11756498 | |
| Pubmed | 2.24e-08 | 43 | 68 | 5 | 12376548 | ||
| Pubmed | Vav proteins are necessary for correct differentiation of mouse cecal and colonic enterocytes. | 2.86e-08 | 4 | 68 | 3 | 19139088 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 17932569 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 20038798 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 22692505 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 21115475 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 17158234 | ||
| Pubmed | Vav proteins regulate the plasma cell program and secretory Ig production. | 2.86e-08 | 4 | 68 | 3 | 17142761 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 20011522 | ||
| Pubmed | Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. | 7.13e-08 | 5 | 68 | 3 | 15456756 | |
| Pubmed | Vav family GEFs link activated Ephs to endocytosis and axon guidance. | 7.13e-08 | 5 | 68 | 3 | 15848800 | |
| Pubmed | Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. | 7.13e-08 | 5 | 68 | 3 | 15365099 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 20634378 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 21209086 | ||
| Pubmed | Vav GEFs regulate macrophage morphology and adhesion-induced Rac and Rho activation. | 7.13e-08 | 5 | 68 | 3 | 19715691 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 15941910 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 22884313 | ||
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 1.24e-07 | 60 | 68 | 5 | 12787561 | |
| Pubmed | Pak and Rac GTPases promote oncogenic KIT-induced neoplasms. | 1.42e-07 | 6 | 68 | 3 | 24091327 | |
| Pubmed | P-Rex and Vav Rac-GEFs in platelets control leukocyte recruitment to sites of inflammation. | 1.42e-07 | 6 | 68 | 3 | 25538043 | |
| Pubmed | An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. | 1.42e-07 | 6 | 68 | 3 | 14502223 | |
| Pubmed | Vav family proteins couple to diverse cell surface receptors. | 1.42e-07 | 6 | 68 | 3 | 10938113 | |
| Pubmed | Interaction of Ras with p110γ is required for thymic β-selection in the mouse. | 1.42e-07 | 6 | 68 | 3 | 21930962 | |
| Pubmed | Vav Proteins Are Key Regulators of Card9 Signaling for Innate Antifungal Immunity. | 1.42e-07 | 6 | 68 | 3 | 27926862 | |
| Pubmed | Rac GTPases play critical roles in early T-cell development. | 1.42e-07 | 6 | 68 | 3 | 19088377 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 16546099 | ||
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 14764585 | ||
| Pubmed | TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. | 2.49e-07 | 7 | 68 | 3 | 21979919 | |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 15173068 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 20308364 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 21178006 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 8276400 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 23345436 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 24659802 | ||
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 24155889 | ||
| Pubmed | Radixin regulates cell migration and cell-cell adhesion through Rac1. | 5.95e-07 | 9 | 68 | 3 | 22467863 | |
| Pubmed | A Protein Scaffold Coordinates SRC-Mediated JNK Activation in Response to Metabolic Stress. | 8.49e-07 | 10 | 68 | 3 | 28930674 | |
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 9.38e-07 | 38 | 68 | 4 | 19911011 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 19141316 | ||
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 22683124 | ||
| Pubmed | 1.55e-06 | 12 | 68 | 3 | 9269777 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23931752 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 31843009 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 29266259 | ||
| Pubmed | The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function. | 3.77e-06 | 2 | 68 | 2 | 35534539 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16150693 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15685634 | ||
| Pubmed | Vav1 and Vav2 play different roles in macrophage migration and cytoskeletal organization. | 3.77e-06 | 2 | 68 | 2 | 16137676 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 37895112 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16950240 | ||
| Pubmed | Maternal Oct-4 is a potential key regulator of the developmental competence of mouse oocytes. | 3.77e-06 | 2 | 68 | 2 | 18837968 | |
| Pubmed | [Investigation of transcriptional regulation of Oct4 (POU5F1) gene with distal enhancer]. | 3.77e-06 | 2 | 68 | 2 | 25509123 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30087437 | ||
| Pubmed | Cruciform Formable Sequences within Pou5f1 Enhancer Are Indispensable for Mouse ES Cell Integrity. | 3.77e-06 | 2 | 68 | 2 | 33810223 | |
| Pubmed | Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. | 3.77e-06 | 2 | 68 | 2 | 18063756 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19664601 | ||
| Pubmed | Distinct Enhancer Activity of Oct4 in Naive and Primed Mouse Pluripotency. | 3.77e-06 | 2 | 68 | 2 | 28157483 | |
| Pubmed | Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines. | 3.77e-06 | 2 | 68 | 2 | 19784378 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28988986 | ||
| Pubmed | Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos. | 3.77e-06 | 2 | 68 | 2 | 18932201 | |
| Pubmed | B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. | 3.77e-06 | 2 | 68 | 2 | 19586920 | |
| Pubmed | Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. | 3.77e-06 | 2 | 68 | 2 | 8710375 | |
| Pubmed | A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. | 3.77e-06 | 2 | 68 | 2 | 1972777 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 1915274 | ||
| Pubmed | Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. | 3.77e-06 | 2 | 68 | 2 | 11376343 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17326776 | ||
| Pubmed | Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. | 3.77e-06 | 2 | 68 | 2 | 11376342 | |
| Pubmed | Mouse Oct-3 maps between the tcl12 embryonic lethal gene and the Qa gene in the H-2 complex. | 3.77e-06 | 2 | 68 | 2 | 1680810 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20376339 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30653498 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23402756 | ||
| Pubmed | Identification and structural basis for a novel interaction between Vav2 and Arap3. | 3.77e-06 | 2 | 68 | 2 | 22750419 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15996113 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21083502 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 26804242 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21502535 | ||
| Pubmed | OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation. | 3.77e-06 | 2 | 68 | 2 | 27499297 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11839818 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34948221 | ||
| Pubmed | Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors. | 3.77e-06 | 2 | 68 | 2 | 28157227 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 33221301 | ||
| Pubmed | Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. | 3.77e-06 | 2 | 68 | 2 | 11309664 | |
| Pubmed | Developmental fate of embryonic germ cells (EGCs), in vivo and in vitro. | 3.77e-06 | 2 | 68 | 2 | 12641567 | |
| Pubmed | A nontranscriptional role for Oct4 in the regulation of mitotic entry. | 3.77e-06 | 2 | 68 | 2 | 25324523 | |
| Pubmed | A novel subpopulation lacking Oct4 expression in the testicular side population. | 3.77e-06 | 2 | 68 | 2 | 16328007 | |
| Pubmed | Novel variants of Oct-3/4 gene expressed in mouse somatic cells. | 3.77e-06 | 2 | 68 | 2 | 18765667 | |
| Pubmed | Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. | 3.77e-06 | 2 | 68 | 2 | 18283123 | |
| Pubmed | Transcriptional activation by Oct4 is sufficient for the maintenance and induction of pluripotency. | 3.77e-06 | 2 | 68 | 2 | 22832160 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16932739 | ||
| Cytoband | 10p15.1 | 7.97e-04 | 28 | 68 | 2 | 10p15.1 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.06e-07 | 66 | 45 | 5 | 722 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.14e-05 | 206 | 45 | 6 | 682 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 3.28e-04 | 11 | 45 | 2 | 559 | |
| GeneFamily | Aldo-keto reductases | 6.23e-04 | 15 | 45 | 2 | 399 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 1.48e-03 | 23 | 45 | 2 | 523 | |
| GeneFamily | NLR family | 1.75e-03 | 25 | 45 | 2 | 666 | |
| GeneFamily | SH2 domain containing | 2.03e-03 | 101 | 45 | 3 | 741 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 1.31e-05 | 199 | 68 | 6 | M7420 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | DCAF1 RNF214 SEC24D HIBCH PTPRS TMEM216 SLC25A10 KEAP1 MAPK3 CDC6 | 3.01e-05 | 776 | 68 | 10 | M1107 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | DCAF1 RNF214 SEC24D HIBCH PTPRS TMEM216 SLC25A10 KEAP1 MAPK3 CDC6 | 3.65e-05 | 794 | 68 | 10 | MM982 |
| Disease | Gilles de la Tourette syndrome (is_implicated_in) | 7.13e-05 | 6 | 65 | 2 | DOID:11119 (is_implicated_in) | |
| Disease | response to risperidone | 8.15e-05 | 38 | 65 | 3 | GO_0097336 | |
| Disease | RAC-beta serine/threonine-protein kinase measurement | 3.67e-04 | 13 | 65 | 2 | EFO_0021989 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 7.98e-04 | 19 | 65 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 7.98e-04 | 19 | 65 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 7.98e-04 | 19 | 65 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 7.98e-04 | 19 | 65 | 2 | C1275081 | |
| Disease | alpha-tocopherol measurement | 8.85e-04 | 20 | 65 | 2 | EFO_0007898 | |
| Disease | serum IgG glycosylation measurement | 1.03e-03 | 523 | 65 | 6 | EFO_0005193 | |
| Disease | LEOPARD Syndrome | 1.07e-03 | 22 | 65 | 2 | C0175704 | |
| Disease | Noonan Syndrome | 1.28e-03 | 24 | 65 | 2 | C0028326 | |
| Disease | multiple myeloma | 1.96e-03 | 112 | 65 | 3 | EFO_0001378 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SNFNCRQLEMILNKP | 166 | P17516 | |
| RPNLLKNMTQLLCVE | 626 | Q8WWN8 | |
| ALNQMCTRNLALLFA | 1046 | Q8WWN8 | |
| FQKCLVNIQALLMDP | 366 | Q86XM0 | |
| LMLIQKLLNENPFKC | 631 | Q5JQC9 | |
| LQMCNPKLLLTAANV | 141 | Q5XX13 | |
| VKALSQLQNLLPLFC | 3861 | Q96M86 | |
| MSLLRNRLQALPALC | 1 | P55056 | |
| LCQPLDVLKTRLMNS | 216 | Q9UBX3 | |
| NNALSKCTLPMFVNL | 601 | Q9ULI1 | |
| LLEHNPNLLFMLKCR | 321 | Q6VN20 | |
| LNRPKFLNALTLNMI | 51 | Q6NVY1 | |
| CPQLANSVQIRIKLM | 86 | Q9UJX4 | |
| LQMCNPKLLLTAANV | 141 | O95170 | |
| QLSFKNMCKLRPLLQ | 191 | Q06416 | |
| SKLPLFSSCQIQQLM | 776 | Q9Y4B6 | |
| RQPMLLFLCQLSAIE | 56 | Q8NH08 | |
| QKSRCLRNLMKTPLF | 326 | Q9NPP4 | |
| PAQFSCLQRLKMLNL | 266 | Q9Y4C4 | |
| CLQRLKMLNLSSNLF | 271 | Q9Y4C4 | |
| LPKQLFNCQALRKLS | 61 | Q96NW7 | |
| RRLCNKPIQSLPNMD | 196 | Q08426 | |
| CLELQPNNLKALMAL | 386 | Q8IYB4 | |
| RFLCKMNPSQALKVR | 251 | Q9H0H0 | |
| LNRFMCSQLPNQVLK | 136 | Q9H223 | |
| CIINMKARNYLQSLP | 271 | P27361 | |
| IINFNCRKLVASMPL | 581 | Q9Y3Q4 | |
| QLSFKNMCKLRPLLQ | 191 | Q01860 | |
| NLPCNKFKNRLVNIM | 1701 | Q13332 | |
| MKPNFSLRLRIFNLN | 1 | O60906 | |
| QDRILPNLSCMFALL | 686 | Q9NSG2 | |
| SFPLQQKILVCSLML | 456 | Q99741 | |
| NMNNCSLILKFRELI | 271 | Q6P1S2 | |
| KTVLLFQRNCLKPNM | 376 | Q5U623 | |
| NFNCMLILLPVCRNL | 61 | P04839 | |
| LTPNFLQMQLQKCEI | 276 | Q14145 | |
| ACLQPSQDPQMRLKL | 611 | Q86Y56 | |
| TDLPLCLQLNIMQRL | 226 | Q969P5 | |
| QCLNPIKAFQGCMRL | 501 | Q8WYK1 | |
| MCNLKDIPNLTALVR | 216 | Q9NT99 | |
| MLNLKILSLYQNPLC | 136 | A6NJI9 | |
| SLAVQAFLQMCNLPI | 41 | O75431 | |
| PLLFLACQLFVINMK | 136 | P59538 | |
| LIFQLLNKLCMAQPR | 51 | Q07890 | |
| NPPCRQKSLQMTFAL | 666 | Q14596 | |
| SLMPNLKLLFLNNNL | 501 | O94933 | |
| LMLQQTCPLCKFNVL | 356 | Q9Y6U7 | |
| PKHFLQMLSLENCRL | 816 | Q8WX94 | |
| INILMQLRKVCNHPN | 891 | Q6ZRS2 | |
| LILQLLNMLCQAQPR | 51 | Q07889 | |
| LNFNCMLILIPVSRN | 61 | Q9HBY0 | |
| QLLKNLINPSCMVRR | 21 | O60518 | |
| MNCLLKNCVLLSRPE | 846 | O94855 | |
| FCLRLMLKNPENHAL | 721 | Q9Y5Q9 | |
| LNRNLRLAMFPITKN | 296 | Q96JD6 | |
| MQKRPLAPSCNELQF | 1656 | O75443 | |
| SNLLNKPCQMAFFRV | 531 | Q9P2M4 | |
| KLLTRFPQCNKAQMT | 561 | Q8ND24 | |
| LGNTQNFMLLCPRLK | 116 | Q2NL82 | |
| TFNAMPKLRILILNN | 466 | Q96PX8 | |
| ENNPEMKCLRNLISL | 346 | Q6ZV50 | |
| NLRPQMSQFLCLKNI | 61 | P15498 | |
| RLMNRPQAILNCVNK | 101 | Q9ULI2 | |
| CKAQMLENPSIQRLL | 171 | Q8IYU4 | |
| LFQVCMALLDNPNSL | 251 | Q7Z5H5 | |
| LARPKSLMQKLQCSF | 236 | Q96DT7 | |
| NFRPQMSQFLCLKNI | 61 | P52735 | |
| LLNILMQLRKCCNHP | 446 | O60264 | |
| LSLPCTLNLQLMRFV | 286 | Q86UV5 | |
| NLCQRKMPLSISVAL | 81 | Q9P0N5 | |
| NLRPQMSQFLCLKNI | 61 | Q9UKW4 |